Revenue (Details) - USD ($) $ in Thousands |
3 Months Ended | |||
---|---|---|---|---|
Jul. 01, 2021 |
Dec. 31, 2024 |
Mar. 31, 2024 |
Mar. 31, 2023 |
|
Disaggregation of Revenue [Line Items] | ||||
Total revenue | $ 0 | $ 475 | ||
Discontinued Operations, Disposed of by Sale | Pediatric Portfolio | ||||
Disaggregation of Revenue [Line Items] | ||||
Other long-term debt | 600 | |||
Discontinued Operations, Disposed of by Sale | Pediatric Portfolio | Forecast | ||||
Disaggregation of Revenue [Line Items] | ||||
Proceeds from divestiture of businesses | $ 1,000 | |||
Product revenue, net | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | $ 0 | $ 475 | ||
Millipred | Teva | ||||
Disaggregation of Revenue [Line Items] | ||||
Percent of net profit for installment payments | 50.00% | |||
Installment payment | $ 500 |
X | ||||||||||
- Definition License Agreement, Installment Payment No definition available.
|
X | ||||||||||
- Definition License Agreement, Percent of Net Profit for Installment Payment No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of long-term debt classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|